62. Impellizeri JA, Tetrick MA, Muir P. Effect of weight reduction on clinical signs of lameness in dogs with hip osteoarthritis.
J Am Vet Med Assoc 2000;216:1089-1091.
63. Smith GK, Kealy RD, Biery DN, et al. Influence of body condition on canine osteoarthritis. Compend Contin Educ Pract Vet 2002;24:8-12.
64. Boston SE, Moens NM, Kruth SA, et al. Endoscopic evaluation of the gastroduodenal mucosa to determine the safety of short-term
concurrent administration of meloxicam and dexamethasone in healthy dogs. Am J Vet Res 2003;64:1369-1375.
65. Reed S. Nonsteroidal anti-inflammatory drug-induced duodenal ulceration and perforation in a mature rottweiler. Can Vet J 2002;43:971-972.
66. McGettigan P, Henry D. Current problems with non-specific COX inhibitors. Curr Pharm Des 2000;6:1693-1724.
67. MacPhail CM, Lappin MR, Meyer DJ, et al. Hepatocellular toxicosis associated with administration of carprofen in 21 dogs.
J Am Vet Med Assoc 1998;212:1895-1901.
68. Holazo AA, Chen SS, McMahon FG, et al. The influence of liver dysfunction on the pharmacokinetics of carprofen. J Clin Pharmacol 1985;25:109-114.
|
Featuring Information from:
